Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
111,129
Value
$6.06M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CRSP by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026111,129$6.06M<0.1%+4,467+4.2%AddedHolders
Q1 2026106,662$5.07M<0.1%−597−0.6%ReducedHolders
Q4 2025107,259$5.62M<0.1%−10,854−9.2%ReducedHolders
Q3 2025118,113$7.65M<0.1%+6,164+5.5%AddedHolders
Q2 2025111,949$5.45M<0.1%+3,531+3.3%AddedHolders
Q1 2025108,418$3.69M<0.1%+23,382+27.5%AddedHolders
Q4 202485,036$3.35M<0.1%+13,289+18.5%AddedHolders
Q3 202471,747$3.37M<0.1%−5,880−7.6%ReducedHolders
Q2 202477,627$4.19M<0.1%+64,076+472.9%AddedHolders
Q1 202413,551$923.0K<0.1%+4,625+51.8%AddedHolders
Q4 20238,926$558.8K<0.1%+3,272+57.9%AddedHolders
Q3 20235,654$254.4K<0.1%+618+12.3%AddedHolders
Q2 20235,036$282.7K<0.1%+59+1.2%AddedHolders
Q1 20234,977$225.1K<0.1%+4,977NewHolders
Q4 20220$00.0%−6,235−100.0%Sold outHolders
Q3 20226,235$407.0K<0.1%+151+2.5%AddedHolders
Q2 20226,084$370.0K<0.1%−358−5.6%ReducedHolders
Q1 20226,442$404.0K<0.1%−5,015−43.8%ReducedHolders
Q4 202111,457$868.0K<0.1%−1,485−11.5%ReducedHolders
Q3 202112,942$1.45M<0.1%+3,083+31.3%AddedHolders
Q2 20219,859$1.60M<0.1%−545−5.2%ReducedHolders
Q1 202110,404$1.27M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.